Objective This study aimed to compare 25-hydroxyvitamin D (25-(OH)D) levels and peripheral lymphocyte subsets between ...

Case 1: A 43-year-old Caucasian woman with fever, acute tonsillitis, nausea and diarrhoea A 43-year-old Caucasian woman with SLE was admitted at the Hospital Clínic of Barcelona with fever, acute ...

Case 1&2: Complex needs and coordinated care of multisystem disease and the cost of a failed transition Transition from pediatric to adult services represents a critical period for young people with ...

Lupus nephritis (LN) remains one of the most severe organ manifestations of systemic lupus erythematosus, affecting up to 50% of patients and carrying substantial risk of progressive renal failure ...

Many biologic drugs used to try and treat patients with systemic lupus erythematosus (SLE) are subsequently used in patients with other autoimmune rheumatic diseases, notably Sjögren’s syndrome. Part ...

Background The short-term and long-term outcome of inflammatory neuropsychiatric SLE (NPSLE) with immunosuppressive treatment is largely unknown. We used clinical data from our tertiary referral ...

Objectives Composite criteria/indices are presently used to diagnose and monitor patients with systemic lupus erythematosus (SLE). Biomarkers for these purposes would be helpful in clinical practice.

Objective We report on the clinical characteristics, treatments and outcomes of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuritis (CIDP) associated with SLE.

Introduction Lupus nephritis (LN) exhibits substantial clinical and pathological heterogeneity. We aimed to define proteomics-based molecular subtypes of LN and identify candidate biomarkers for ...

Objective Lupus nephritis (LN) is a potentially severe manifestation of SLE, often resulting in permanent kidney damage. We investigated whether polygenic and/or epigenetic risk is associated with ...

Objectives Voclosporin is approved for the treatment of adults with active lupus nephritis (LN). In the Phase 3 AURORA studies, voclosporin plus mycophenolate mofetil and low-dose glucocorticoids led ...

Background Proliferating cell nuclear antigen (PCNA) antibodies are a rare type of antinuclear antibodies (ANA), historically considered highly specific for systemic lupus erythematosus (SLE). Recent ...